BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee HW, Suh K. Advancements of liver transplantation for hepatocellular carcinoma in Korea. Japanese Journal of Clinical Oncology 2017;47:93-100. [DOI: 10.1093/jjco/hyw168] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lerut J, Iesari S, Vandeplas G, Fabbrizio T, Ackenine K, Núñez MEI, Komuta M, Coubeau L, Ciccarelli O, Bonaccorsi-riani E. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series. Hepatobiliary & Pancreatic Diseases International 2019;18:412-22. [DOI: 10.1016/j.hbpd.2019.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Sakamoto Y. Editorial for Liver Cancer in Asia. Jpn J Clin Oncol 2018;48:955-6. [PMID: 30277510 DOI: 10.1093/jjco/hyy143] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Liang HR, Hsieh CE, Lin KH, Ko CJ, Hung YJ, Hsu YL, Chen YL. Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size. BMC Surg 2021;21:401. [PMID: 34798847 DOI: 10.1186/s12893-021-01403-z] [Reference Citation Analysis]
4 Lee HW, Song G, Lee S, Kim JM, Joh J, Han DH, Kim SI, Kim SH, Kim D, Cho JY, Suh K. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma: Lee et al. Liver Transpl 2018;24:1243-51. [DOI: 10.1002/lt.25056] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
5 Jeong YH, Hwang S, Lee GD, Choi SH, Kim HR, Kim YH, Park SI, Kim DK. Surgical Outcome of Pulmonary Metastasectomy for Hepatocellular Carcinoma Recurrence in Liver Transplant Patients. Ann Transplant 2021;26:e930383. [PMID: 33972494 DOI: 10.12659/AOT.930383] [Reference Citation Analysis]